Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|November 15, 1989
Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell lineA Hall, C N Robson, I D Hickson, et al.
The Journal of Biological Chemistry|June 11, 1999
Tip60 is a nuclear hormone receptor coactivatorM E Brady, D M Ozanne, L Gaughan, et al.
British Journal of Cancer|November 6, 2009
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical diseaseS Darby, T Murphy, H Thomas, et al.
The Journal of Pathology|February 15, 2008
The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptorP Rajan, L Gaughan, C Dalgliesh, et al.
Oncogene|March 6, 2003
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasionP B Mehta, B L Jenkins, L McCarthy, et al.
British Journal of Cancer|December 17, 2009
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cellsN Johnson, J Bentley, L-Z Wang, et al.
British Journal of Cancer|November 20, 1998
Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignanciesP Autzen, C N Robson, A Bjartell, et al.
Cancer Research|December 15, 1990
Activation of mitomycin C by NADPH:cytochrome P-450 reductaseH F Bligh, A Bartoszek, C N Robson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinomaG P Collett, A M Betts, M I Johnson, et al.
British Journal of Cancer|July 25, 2013
Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancerS C Williamson, R Mitter, A C Hepburn, et al.
Pageof 8